- Mar 10, 2009
- 2,973
- 5
- 11,485
Re:
Keep in mind that the proportion of such science conducted on elite/pro level cyclists isn't large. Test subjects are often not selected from the pro ranks but from healthy population samples of sub-elite cyclists.
e.g. here's a study examining the effect of removing some blood on O2 uptake kinetics and exercise tolerance, and also makes direct comparison with impacts of RhEPO injection as per earlier research.
http://onlinelibrary.wiley.com/doi/10.1113/expphysiol.2005.032805/full
Subjects were healthy non elites (just like the study you linked earlier), as were the subjects in two referenced studies that examined impact of RhEPO injection.
So there is "real science" that does consider the effect of doping (in this case EPO) and compares it to other interventions.
			
			Actually we won't. It still would not be possible to legitimately parse out the specific impact of doping substances/methods from all the other factors.sniper said:good points 42x16ss.
and I think that Swarts 2015 work on Froome should for those reasons indeed be viewed mildly/positively.
However, while Swart has probably done a methodologically sound job on Froome 2015, I do think he, and the field as a whole, should strive for much much more. The goal of Swart, and of sports science as a whole, cannot be to continue producing insignificant test results.
Then, the irony of Swart's 2015 test results on Froome is that they will become truly relevant for the field only once we know the kind of drugs Froome has been on. Only then can we draw some useful conclusions from it, e.g. in terms of what impact a combination of AICAR with microdosed EPO can have on VO2max.
Even in the absence of reliable 2007 data: his realtime road performances from the prevuelta'11 period give us enough of an impression so as to allow for informed speculation.
Why? It's not like it was a study on pro riders.sniper said:On a side, other work by Swart seems more questionable in terms of why doping/peds aren't at all mentioned as a possible variable.
For instance, https://www.researchgate.net/profile/Robert_Lamberts/publication/23683240_Changes_in_heart_rate_recovery_after_high-intensity_training_in_well-trained_cyclists/links/0c9605200f925314c7000000.pdf
In such a study, the topic of PEDs and their possible impact on the results should at least be touched upon.
Keep in mind that the proportion of such science conducted on elite/pro level cyclists isn't large. Test subjects are often not selected from the pro ranks but from healthy population samples of sub-elite cyclists.
e.g. here's a study examining the effect of removing some blood on O2 uptake kinetics and exercise tolerance, and also makes direct comparison with impacts of RhEPO injection as per earlier research.
http://onlinelibrary.wiley.com/doi/10.1113/expphysiol.2005.032805/full
Subjects were healthy non elites (just like the study you linked earlier), as were the subjects in two referenced studies that examined impact of RhEPO injection.
So there is "real science" that does consider the effect of doping (in this case EPO) and compares it to other interventions.
 
				
		 
			 
 
		 
 
		 
 
		 
 
		 
 
		 
 
		 
		
		 
		
		 
 
		 
 
		 
		
		 
 
		 
 
		 
 
		
 Facebook
Facebook Twitter
Twitter Instagram
Instagram